Medicare Enrolled

Chelsi Clayton, FNP

Physician Assistant · Vidor, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
515 S ARCHIE ST, Vidor, TX 77662
4097692295
Registered in NPPES since 2018
NPI: 1760974711 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Clayton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Clayton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Clayton

Chelsi Clayton is a physician assistant in Vidor, TX, with 8 years of NPI registration. Based on federal Medicare data, Clayton performed 778 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Clayton received a total of $4,684 from 24 pharmaceutical and/or device companies across 282 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Clayton is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years of NPI registration ▲ Top 17% volume in TX $4,684 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
778
Medicare services
Top 17% in TX for physician assistant
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
248 $63 $267
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
220 $41 $180
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
131 $8 $43
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
64 $6 $45
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
50 $105 $325
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
31 $3 $48
Drug test with direct observation
A drug screening test performed under direct observation to ensure the sample is provided correctly. This method is used to verify the integrity of the specimen collection process.
20 $12 $38
COVID-19 amplified DNA/RNA probe detection
A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen.
14 $50 $159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,684
Total received (2021-2024)
Avg $1,171/year across 4 years
Top 7% in TX for physician assistant
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
282
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,198
2023
$1,431
2022
$1,015
2021
$1,040

Payments by company (2024)

ABBVIE INC.
$351
Takeda Pharmaceuticals U.S.A., Inc.
$185
AstraZeneca Pharmaceuticals LP
$156
Amgen Inc.
$137
PFIZER INC.
$87
Bayer Healthcare Pharmaceuticals Inc.
$75
Teva Pharmaceuticals USA, Inc.
$51
Astellas Pharma US Inc
$36
GlaxoSmithKline, LLC.
$31
IDORSIA PHARMACEUTICALS US INC
$22
E.R. Squibb & Sons, L.L.C.
$20
Neurocrine Biosciences, Inc.
$17
Sumitomo Pharma America, Inc.
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$14
Top 3 companies account for 57.8% of 2024 payments
All-time payments by company (2021-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$1,068
ABBVIE INC.
$1,038
Amgen Inc.
$482
AstraZeneca Pharmaceuticals LP
$341
Novo Nordisk Inc
$289
GlaxoSmithKline, LLC.
$282
AbbVie Inc.
$271
Astellas Pharma US Inc
$202
PFIZER INC.
$127
Lilly USA, LLC
$114
Bayer Healthcare Pharmaceuticals Inc.
$75
Sumitomo Pharma America, Inc.
$65
IDORSIA PHARMACEUTICALS US INC
$54
Teva Pharmaceuticals USA, Inc.
$51
Kowa Pharmaceuticals America, Inc.
$51
Boehringer Ingelheim Pharmaceuticals, Inc.
$27
Genentech USA, Inc.
$25
E.R. Squibb & Sons, L.L.C.
$20
SCILEX PHARMACEUTICALS INC.
$19
EISAI INC.
$18
Merck Sharp & Dohme Corporation
$18
Neurocrine Biosciences, Inc.
$17
Biohaven Pharmaceutical Holding Company Ltd.
$16
Averitas Pharma Inc.
$13
Top 3 companies account for 55.3% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · AREXVY · Aimovig · Austedo XR · BREZTRI · COBENFY · Dayvigo · ELIQUIS · EMGALITY · FARXIGA · GEMTESA · INGREZZA · JANUVIA · JARDIANCE · Kerendia · MOUNJARO · NURTEC ODT · Otezla · Ozempic · PREMARIN · QULIPTA · QUTENZA · QUVIVIQ · Repatha · Rybelsus · SEGLENTIS · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · UBRELVY · VRAYLAR · Veozah · Xofluza · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a physician assistant in Vidor?
Compare physician assistants in the Vidor area by procedure volume, costs, and industry payment transparency.
Browse physician assistants nearby

Geographic Context

Physician assistants in nearby ZIP areas
76
County median income
$73,372
Nearest hospital to ZIP centroid (approximate)
BAPTIST BEAUMONT HOSPITAL
8.9 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Clayton is a clinical cardiology specialist, with above-average Medicare volume (top 17% in TX).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Clayton experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Clayton performed 248 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Clayton receive payments from pharmaceutical companies?
Yes. Clayton received a total of $4,684 from 24 companies across 282 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Clayton's costs compare to other physician assistants in Vidor?
Clayton's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Clayton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →